SCORE2

Clinical Trials // Macular Edema // Michael Altaweel // Past // Retinal Vein Occlusion // Sep 30 2020

A Multicenter, Prospective, Randomized Non-Inferiority Trial of Eyes with Macular Edema Secondary to Central Retinal Vein Occlusion, Comparing Intravitreal Bevacizumab Every 4 Weeks with Intravitreal Aflibercept Every 4 Weeks

Sponsor: The Emmes Company, LLC

CLINICALTRIALS.GOVĀ